Rybelsus
Active Ingredient(s): SemaglutideFDA Approved: * September 20, 2019
Pharm Company: * NOVO NORDISK INC
Category: Diabetes
Semaglutide, sold under the brand name Ozempic among others, is an antidiabetic medication used for the treatment of type 2 diabetes and long-term weight management.[15][16][17] Semaglutide acts like human glucagon-like peptide-1 (GLP-1) in that it increases insulin secretion, thereby increasing sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen, or as an oral form. One of its advantages over other antidia... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.